Regarding the role of obestatin in NAFLD/NASH, there was a negative correlation between serum concentration of ghrelin and obestatin and overweight status, obesity, and MetS in NAFLD patients. This evidence concerns the gene GHRL and metabolic dysfunction-associated steatotic liver disease.